Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu -Q1 group results

Jul 6 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2018        May 31, 2017     Feb 28, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               33.50               36.08           148.50    
                   (-7.2 pct)          (-5.4 pct)       (+0.4 pct)  
  Operating            4.35                5.09            24.00    
                   (-14.4 pct)         (-11.4 pct)      (-8.9 pct)  
  Recurring            4.45                4.94            26.30    
                   (-10.0 pct)         (-11.2 pct)      (-6.9 pct)  
  Net                  3.45                3.67            19.20    
                   (-6.0 pct)          (-18.9 pct)      (+0.4 pct)  
  EPS               41.27 yen           43.92 yen       229.49 yen  
  EPS Diluted       41.23 yen           43.89 yen                   
  Ann Div                               82.00 yen        82.50 yen  
  -Q2 div                               41.00 yen        41.25 yen  
  -Q4 div                               41.00 yen        41.25 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T

Recent news on Hisamitsu Pharmaceutical Co

See all news